Molecular Cancer

Oncogenic Signaling of Tyrosine Kinase in Cancer: Challenges and Therapeutic Opportunities

Newly Published: Molecular Cancer is proud to finally present a curated selection of literature reviews. Find out more here.

Articles

Recent
Most accessed

Content type: Review
| 21 July 2018

Novel insights on m⁶A RNA methylation in tumorigenesis: a double-edged sword

Authors: Shaoyun Wang, Peiwei Chai, Ruobing Jia and Renbing Jia
Content type: Research
| 16 July 2018

Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer

Authors: Steven C. Eastlack, Shengli Dong, Cristina Ivan and Suresh K. Alahari
Content type: Research
| 16 July 2018

Transcriptome reprogramming by cancer exosomes: identification of novel molecular targets in matrix and immune modulation

Authors: Fatima Qadir, Mohammad Arshad Aziz, Chrisdina Puspita Sari, Hong Ma, Haiyan Dai, Xun Wang, Dhiresh Raithatha, Lucas Girotto Lagreca Da Silva, Muhammad Hussain, Seyedeh P. Poorkasreiy, Iain L. Hutchison, Ahmad Waseem and Muy-Teck Teh
Content type: Review
| 14 July 2018

Therapeutic landscape in mutational triple negative breast cancer

Authors: Yaqin Shi, Juan Jin, Wenfei Ji and Xiaoxiang Guan
Content type: Research
| 12 July 2018

LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis

Authors: Fengting Huang, Wenying Chen, Juanfei Peng, Yuanhua Li, Yanyan Zhuang, Zhe Zhu, Chunkui Shao, Wanling Yang, Herui Yao and Shineng Zhang

Most recent articles RSS

View all articles

Content type: Research
| 28 September 2014

Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer

Authors: Ruochuan Sun, Jifeng Wu, Yuanyuan Chen, Mingdian Lu, Shangxin Zhang, Daru Lu and Yongxiang Li
Content type: Research
| 9 October 2014

Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer

Authors: Donatella Del Bufalo, Marianna Desideri, Teresa De Luca, Marta Di Martile, Chiara Gabellini, Valentina Monica, Simone Busso, Adriana Eramo, Ruggero De Maria, Michele Milella and Daniela Trisciuoglio
Content type: Review
| 2 August 2013

The complexity of NF-κB signaling in inflammation and cancer

Authors: Bastian Hoesel and Johannes A Schmid
Content type: Research
| 22 July 2010

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

Authors: María M Caffarel, Clara Andradas, Emilia Mira, Eduardo Pérez-Gómez, Camilla Cerutti, Gema Moreno-Bueno, Juana M Flores, Isabel García-Real, José Palacios, Santos Mañes, Manuel Guzmán and Cristina Sánchez
Content type: Review
| 29 May 2014

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

Authors: Mildred Felder, Arvinder Kapur, Jesus Gonzalez-Bosquet, Sachi Horibata, Joseph Heintz, Ralph Albrecht, Lucas Fass, Justanjyot Kaur, Kevin Hu, Hadi Shojaei, Rebecca J Whelan and Manish S Patankar

Most accessed articles RSS

View all articles

Editor-in-Chief

Christophe Nicot, Kansas University Medical Center, USA

Aims and scope

Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.

Impact Factor

Molecular Cancer has an Impact Factor of 7.776 and is ranked in the top 10% of both its JCR Categories.

It is currently ranked at 27 out of 292 (Q1) in the Biochemistry and Molecular Biology category and 22 out of 222 (Q1) in the Oncology category of Journal Citation Reports.

Molecular Cancer

Oncogenic Signaling of Tyrosine Kinase in Cancer: Challenges and Therapeutic Opportunities

Articles

Novel insights on m⁶A RNA methylation in tumorigenesis: a double-edged sword

Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer

Transcriptome reprogramming by cancer exosomes: identification of novel molecular targets in matrix and immune modulation

Therapeutic landscape in mutational triple negative breast cancer

LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis

Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer

Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer

The complexity of NF-κB signaling in inflammation and cancer

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

Editor-in-Chief

Aims and scope

Impact Factor

2017 Journal Metrics

Molecular Cancer

Contact us